PALATIN TECHNOLOGIES, INC. Amortization of Debt Discount (Premium)
PALATIN TECHNOLOGIES, INC. (PTN) reported Amortization of Debt Discount (Premium) of $0 for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2021-05-14
- PALATIN TECHNOLOGIES, INC. amortization of debt discount (premium) for the quarter ending 2021-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. amortization of debt discount (premium) for the quarter ending 2020-12-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. amortization of debt discount (premium) for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. amortization of debt discount (premium) for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. amortization of debt discount (premium) for fiscal 2017 was -$11.60K.
- PALATIN TECHNOLOGIES, INC. amortization of debt discount (premium) for fiscal 2016 was -$4.52K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 | |||
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $438.00 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $438.00 10-Q · filed 2021-02-16 | ||
| 2019-09-30 | $438.00 10-Q · filed 2020-11-16 | |||
| 2019-03-31 | $7.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $23.73K derived: sum of 2 quarters · filed 2020-05-11 | $47.31K 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $15.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10 | $39.46K 10-Q · filed 2020-02-10 | ||
| 2018-09-30 | $23.58K 10-Q · filed 2019-11-12 | |||
| 2018-03-31 | $39.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | $87.66K derived: sum of 2 quarters · filed 2019-05-09 | $143.84K 10-Q · filed 2019-05-09 | -$101.81K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $47.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | $104.11K 10-Q · filed 2019-02-11 | -$141.54K derived: sum of 3 quarters · filed 2019-02-11 | -$68.20K derived: sum of 4 quarters · filed 2019-02-11 |
| 2017-09-30 | $56.18K 10-Q · filed 2018-11-09 | -$189.47K derived: sum of 2 quarters · filed 2018-11-09 | -$116.13K derived: sum of 3 quarters · filed 2018-11-09 | -$37.68K derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$245.65K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-13 | -$172.31K derived: sum of 2 quarters · filed 2018-09-13 | -$93.86K derived: sum of 3 quarters · filed 2018-09-13 | -$11.60K 10-K · filed 2018-09-13 |
| 2017-03-31 | $73.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $151.79K derived: sum of 2 quarters · filed 2018-05-14 | $234.06K 10-Q · filed 2018-05-14 | -$14.94K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $78.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | $160.71K 10-Q · filed 2018-02-12 | -$88.29K derived: sum of 3 quarters · filed 2018-02-12 | -$5.29K derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-09-30 | $82.27K 10-Q · filed 2017-11-13 | -$166.73K derived: sum of 2 quarters · filed 2017-11-13 | -$83.73K derived: sum of 3 quarters · filed 2017-11-13 | -$3.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | -$249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$166.00K derived: sum of 2 quarters · filed 2017-09-25 | -$85.26K derived: sum of 3 quarters · filed 2017-09-25 | -$4.52K 10-K · filed 2017-09-25 |
| 2016-03-31 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $163.74K derived: sum of 2 quarters · filed 2017-05-15 | $244.48K 10-Q · filed 2017-05-15 | |
| 2015-12-31 | $80.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | $161.48K 10-Q · filed 2017-02-10 | ||
| 2015-09-30 | $80.74K 10-Q · filed 2016-11-14 | |||
| 2015-03-31 | $84.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | $93.42K 10-Q · filed 2016-05-16 | ||
| 2014-12-31 | $8.49K 10-Q · filed 2016-02-12 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |